Cited by 1,010SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesAdvanced Proteomics Techniques and Applications

The DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

Open access

Bojkova, Denisa, Klann, Kevin, Koch, Benjamin, Widera, Marek, Krause, David, Ciesek, Sandra, Cinatl, Jindrich, Münch, Christian·2020·Nature

DOI 10.1038/s41586-020-2332-7PMC PMC7616921

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

A new coronavirus was recently discovered and named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Infection with SARS-CoV-2 in humans causes coronavirus disease 2019 (COVID-19) and has been rapidly spreading around the globe 1,2. SARS-CoV-2 shows some similarities to other coronaviruses; however, treatment options and an understanding of how SARS-CoV-2 infects cells are lacking. Here we identify the host cell pathways that are modulated by SARS-CoV-2 and show that inhibition of these pathways prevents viral replication in human cells. We established a human cell-culture model for infection with a clinical isolate of SARS-CoV-2. Using this cell-culture system, we determined the infection profile of SARS-CoV-2 by translatome 3 and proteome proteomics at different times after infection. These analyses revealed that SARS-CoV-2 reshapes central cellular pathways such as translation, splicing, carbon metabolism, protein homeostasis (proteostasis) and nucleic acid metabolism. Small-molecule inhibitors that target these pathways prevented viral replication in cells. Our results reveal the cellular infection profile of SARS-CoV-2 and have enabled the identification of drugs that inhibit viral replication. We anticipate that our results will guide efforts to understand the molecular mechanisms that underlie the modulation of host cells after infection with SARS-CoV-2. Furthermore, our findings provide insights for the development of therapies for the treatment of COVID-19.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41586-020-2332-7

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Data Structures for Statistical Computing in Python
McKinney, W. (2010) · Proceedings of the Python in Science Conferences · doi:10.25080/majora-92bf1922-00a · Cited by 12,930
The NumPy Array: A Structure for Efficient Numerical Computation
van der Walt, S., Colbert, S. C., & Varoquaux, G. (2011) · Computing in Science & Engineering · doi:10.1109/mcse.2011.37 · Cited by 9,381
The Perseus computational platform for comprehensive analysis of (prote)omics data
Tyanova, S., Temu, T., Sinitcyn, P., Carlson, A., Hein, M. Y., Geiger, T., Mann, M., & Cox, J. (2016) · Nature Methods · doi:10.1038/nmeth.3901 · Cited by 8,803
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
Chan, J., Yuan, S.-F., Kok, K.-H., To, K., Chu, H., Yang, J., Xing, F., Liu, J.-L., Yip, C., Poon, R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,450
A scaling normalization method for differential expression analysis of RNA-seq data
Robinson, M. D., & Oshlack, A. (2010) · Genome Biology · doi:10.1186/gb-2010-11-3-r25 · Cited by 7,876

Show all 53 references

Sorted by citations

Items 101–200 of 998

Data, Reagents, Assays and Merits of Proteomics for SARS-CoV-2 Research and Testing
Zecha, J., Lee, C., Bayer, F. P., Meng, C., Grass, V., Zerweck, J., Schnatbaum, K., Michler, T., Pichlmair, A., Ludwig, C., et al. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra120.002164 · Cited by 81
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection
Chen, P., Wu, M., He, Y., Jiang, B., & He, M. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01510-8 · Cited by 89
Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs
Toptan, T., Hoehl, S., Westhaus, S., Bojková, D., Berger, A., Rotter, B., Hoffmeier, K., Cinatl, J. J., Ciesek, S., & Widera, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124396 · Cited by 80
Self-citation
COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19
Costanzo, M., Caterino, M., Fedele, R., Cevenini, A., Pontillo, M., Barra, L., & Ruoppolo, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052414 · Cited by 78
A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection
Ellinger, B., Bojková, D., Zaliani, A., Cinatl, J. J., Claussen, C., Westhaus, S., Keminer, O., Reinshagen, J., Kuzikov, M., Wolf, M., et al. (2021) · Scientific Data · doi:10.1038/s41597-021-00848-4 · Cited by 79
Self-citation
Endotheliopathy Is Induced by Plasma From Critically Ill Patients and Associated With Organ Failure in Severe COVID-19
Rauch, A., Dupont, A., Goutay, J., Caplan, M., Staessens, S., Moussa, M. D., Jeanpierre, E., Corseaux, D., Lefèvre, G., Lassalle, F., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.050907 · Cited by 80
Changes in Glycolytic Pathway in SARS-COV 2 Infection and Their Importance in Understanding the Severity of COVID-19
Santos, A. F. D., Póvoa, P. M. S. R., Paixão, P., Mendonça, A., & Taborda‐Barata, L. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.685196 · Cited by 77
Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives
Mahmud, I., & Garrett, T. J. (2020) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.0c00238 · Cited by 80
Recent advances in developing small-molecule inhibitors against SARS-CoV-2
Xiang, R., Yu, Z., Wang, Y., Wang, L., Huo, S., Li, Y., Liang, R., Hao, Q., Ying, T., Gao, Y., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.016 · Cited by 77
Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections
Stubbs, B. J., Koutnik, A. P., Goldberg, E. L., Upadhyay, V., Turnbaugh, P. J., Verdin, E., & Newman, J. C. (2020) · Med · doi:10.1016/j.medj.2020.06.008 · Cited by 71
Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children
Beckmann, N. D., Comella, P., Cheng, E., Lepow, L., Beckmann, A. G., Tyler, S. R., Mouskas, K., Simons, N. W., Hoffman, G. E., Francoeur, N. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24981-1 · Cited by 71
Aberrant NAD+ metabolism underlies Zika virus–induced microcephaly
Pang, H., Jiang, Y., Li, J., Wang, Y., Nie, M., Xiao, N., Wang, S., Song, Z., Ji, F., Chang, Y., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00437-0 · Cited by 77
Host metabolic reprogramming in response to SARS-CoV-2 infection: A systems biology approach
Moolamalla, S. T. R., Balasubramanian, R., Chauhan, R., Priyakumar, U. D., & Vinod, P. K. U. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105114 · Cited by 82
Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism
Shao, Y., Saredy, J., Xu, K., Sun, Y., Saaoud, F., Drummer, C., Lu, Y., Luo, J. J., Lopez‐Pastrana, J., Choi, E. T., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.653110 · Cited by 75
SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics
Karthik, R., Maity, S., Muthukumar, A. R., Kandala, S., Tomar, D., El‐Aziz, T. M. A., Allen, C., Sun, Y., Venkatesan, M., Madaris, T. R., et al. (2022) · iScience · doi:10.1016/j.isci.2021.103722 · Cited by 72
Mitochondrial Dysfunction and Coenzyme Q10 Supplementation in Post-Viral Fatigue Syndrome: An Overview
Mantle, D., Hargreaves, I. P., Domingo, J. C., & Castro‐Marrero, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010574 · Cited by 70
Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines
Grenga, L., Gallais, F., Pible, O., Gaillard, J., Gouveia, D., Batina, H., Bazaline, N., Ruat, S., Culotta, K., Miotello, G., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1791737 · Cited by 67
Host PDZ‐containing proteins targeted by SARS‐CoV‐2
Caillet‐Saguy, C., Durbesson, F., Rezelj, V. V., Gógl, G., Tran, Q. D., Twizere, J., Vignuzzi, M., Vincentelli, R., & Wolff, N. (2021) · FEBS Journal · doi:10.1111/febs.15881 · Cited by 69
SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases
Murugan, A. K., & Alzahrani, A. S. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s332705 · Cited by 72
Urine proteome of COVID-19 patients
(2020) · doi:10.1016/j.urine.2021.02.001 · Cited by 68
An airway organoid-based screen identifies a role for the HIF1α-glycolysis axis in SARS-CoV-2 infection
Duan, X., Tang, X., Nair, M. S., Zhang, T., Qiu, Y., Zhang, W., Wang, P., Huang, Y., Xiang, J., Wang, H., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109920 · Cited by 66
Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder
Chen, T., Chang, C.-J., & Hung, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098034 · Cited by 73
Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2
Saccon, E., Chen, X., Mikaeloff, F., Murillo, J. R., Székely, L., Vinhas, B. S., Krishnan, S., Byrareddy, S. N., Frisan, T., Végvári, Á., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102420 · Cited by 67
Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19
Liu, J., Liu, S., Zhang, Z., Lee, X., Wu, W., Huang, Z., Lei, Z., Xu, W., Chen, D., Wu, X., et al. (2021) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2021.06.002 · Cited by 64
Alteration in Cellular Signaling and Metabolic Reprogramming during Viral Infection
Pant, A., Dsouza, L., & Yang, Z. (2021) · mBio · doi:10.1128/mbio.00635-21 · Cited by 66
Coronaviruses in cattle
Hodnik, J. J., Ježek, J., & Starič, J. (2020) · Tropical Animal Health and Production · doi:10.1007/s11250-020-02354-y · Cited by 67
Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis
Kumar, N., Mishra, B., Mehmood, A., Athar, M., & Mukhtar, M. S. (2020) · iScience · doi:10.1016/j.isci.2020.101526 · Cited by 63
SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in CellsPreprint
Andres, A. D., Feng, Y., Campos, A. R., Yin, J., Yang, C.-C., James, B. P., Murad, R., Kim, H., Deshpande, A. J., Gordon, D. E., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.18.256776 · Cited by 67
Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications
Mészáros, B., Sámano‐Sánchez, H., Alvarado-Valverde, J., Čalyševa, J., Martínez‐Pérez, E., Alves, R., Shields, D. C., Kumar, M., Rippmann, F., Chemes, L. B., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abd0334 · Cited by 67
Glycolytic Inhibitor 2-Deoxy-D-Glucose Attenuates SARS-CoV-2 Multiplication in Host Cells and Weakens the Infective Potential of Progeny Virions
Bhatt, A. N., Kumar, A., Rai, Y., Kumari, N., Vedagiri, D., Harshan, K. H., Chinnadurai, V., & Chandna, S. (2021) · Life Sciences · doi:10.1016/j.lfs.2022.120411 · Cited by 65
SARS-CoV-2 down-regulates ACE2 through lysosomal degradation
Lu, Y., Zhu, Q., Fox, D., Gao, C., Stanley, S. A., & Luo, K. (2022) · Molecular Biology of the Cell · doi:10.1091/mbc.e22-02-0045 · Cited by 66
COVID-19 management in light of the circadian clock
Ray, S., & Reddy, A. B. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0275-3 · Cited by 65
Targeting glucose metabolism for treatment of COVID-19
Ardestani, A. D., & Azizi, Z. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00532-4 · Cited by 64
Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets
Haas, K. M., McGregor, M., Bouhaddou, M., Polacco, B. J., Kim, E., Nguyen, T. T., Newton, B. W., Urbanowski, M., Kim, H. J., Williams, M. A. P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41442-z · Cited by 65
Genes with 5′ terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 Nsp1 protein
Rao, S. J., Hoskins, I., Tonn, T., Garcia, P. D., Özadam, H., Cenik, E. S., & Cenik, C. (2021) · RNA · doi:10.1261/rna.078661.120 · Cited by 63
Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collectionPreprint
Ellinger, B., Bojková, D., Zaliani, A., Cinatl, J. J., Claussen, C., Westhaus, S., Reinshagen, J., Kuzikov, M., Wolf, M., Geißlinger, G., et al. (2020) · doi:10.21203/rs.3.rs-23951/v1 · Cited by 63
Self-citation
Choosing a cellular model to study SARS-CoV-2
de Souza, G. A. P., Bideau, M. L., Boschi, C., Wurtz, N., Colson, P., Aherfi, S., Devaux, C. A., & Scola, B. L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1003608 · Cited by 63
Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight
Bhowal, C., Ghosh, S., Ghatak, D., & De, R. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04593-z · Cited by 63
Identification and Tracking of Antiviral Drug Combinations
Ianevski, A., Yao, R., Biza, S., Žusinaite, E., Männik, A., Kivi, G., Planken, A., Kurg, K., Tombak, E.-M., Ustav, M., et al. (2020) · Viruses · doi:10.3390/v12101178 · Cited by 60
Metabolic Reprogramming in COVID-19
Shen, T., & Wang, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111475 · Cited by 61
Therapeutic potential of targeting LSD1/ KDM1A in cancers
Zhang, X., Wang, X., Wu, T., Yin, W., Yan, J., Sun, Y., & Zhao, D. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105958 · Cited by 61
Cholesterol: A new game player accelerating vasculopathy caused by SARS-CoV-2?
Cao, X., Yin, R. H., Albrecht, H., Fan, D., & Tan, W. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00255.2020 · Cited by 58
Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development
Zhu, Y., Li, J., & Pang, Z. (2020) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2020.06.001 · Cited by 59
Transcriptome analysis of cepharanthine against a SARS-CoV-2-related coronavirus
Li, S., Liu, W., Chen, Y., Wang, L., An, W., An, X., Song, L., Tong, Y., Fan, H., & Lu, C. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa387 · Cited by 58
Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications
Mészáros, B., Sámano Sánchez, H., Alvarado Valverde, J., Čalyševa, J., Martinez Perez, E., Alves, R., Shields, D. C., Kumar, M., Rippmann, F., Chemes, L. B., et al. (2021) · CONICET Digital (CONICET) · Cited by 59
Metabolic Alterations in SARS-CoV-2 Infection and Its Implication in Kidney Dysfunction
Andrade-Silva, M., da Silva, A. R. P. A., do Amaral, M. A., de Fragas, M. G., & Câmara, N. O. S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.624698 · Cited by 60
Development and application of therapeutic antibodies against COVID-19
Lin, N., Abagna, H. B., Jiang, Q., Liu, S., & Huang, J. H. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59149 · Cited by 61
The Rationale for Potential Pharmacotherapy of COVID-19
Saber-Ayad, M. M., Saleh, M. A., & Abu‐Gharbieh, E. (2020) · Pharmaceuticals · doi:10.3390/ph13050096 · Cited by 59
Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer
Signore, M., Alfonsi, R., Federici, G., Nanni, S., Addario, A., Bertuccini, L., Aiello, A., Pace, A. L. D., Sperduti, I., Muto, G., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03909-z · Cited by 59
Estrogen hormone is an essential sex factor inhibiting inflammation and immune response in COVID-19
Li, F., Boon, A. C. M., Michelson, A. P., Foraker, R. E., Zhan, M., & Payne, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-13585-4 · Cited by 62
COVID-19 and pregnancy: clinical outcomes; mechanisms, and vaccine efficacy
Kumar, D., Verma, S., & Mysorekar, I. U. (2022) · Translational research · doi:10.1016/j.trsl.2022.08.007 · Cited by 59
Multiomics approach reveals the ubiquitination-specific processes hijacked by SARS-CoV-2
Xu, G., Wu, Y., Xiao, T., Qi, F., Fan, L., Zhang, S., Zhou, J., He, Y., Gao, X., Zeng, H., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01156-y · Cited by 56
COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks
Blaess, M. F., Kaiser, L., Sauer, M., Csük, R., & Deigner, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144953 · Cited by 57
Targeted in situ cross-linking mass spectrometry and integrative modeling reveal the architectures of three proteins from SARS-CoV-2
Slavin, M., Zamel, J., Zohar, K., Eliyahu, T., Braitbard, M., Brielle, E. S., Baraz, L., Stolovich-Rain, M., Friedman, A., Wolf, D. G., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103554118 · Cited by 55
Mass Spectrometry-Based Human Breath Analysis: Towards COVID-19 Diagnosis and Research
Yuan, Z., & Hu, B. (2021) · Journal of Analysis and Testing · doi:10.1007/s41664-021-00194-9 · Cited by 58
Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2
Chen, N., Zhang, B., Deng, L., Liang, B., & Ping, J. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2071175 · Cited by 57
Re-analysis of SARS-CoV-2-infected host cell proteomics time-course data by impact pathway analysis and network analysis: a potential link with inflammatory response
Ortea, I., & Bock, J.-O. (2020) · Aging · doi:10.18632/aging.103524 · Cited by 55
On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2
Sauvat, A., Ciccosanti, F., Colavita, F., Rienzo, M. D., Castilletti, C., Capobianchi, M. R., Kepp, O., Zitvogel, L., Fimia, G. M., Piacentini, M., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02842-x · Cited by 55
A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19
Logette, E., Lorin, C., Favreau, C., Oshurko, E., Coggan, J. S., Casalegno, F., Sy, M. F., Monney, C., Bertschy, M., Delattre, É., et al. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.695139 · Cited by 58
Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients
Schmelter, F., Föh, B., Mallagaray, Á., Rahmöller, J., Ehlers, M., Lehrian, S., von Kopylow, V., Künsting, I., Lixenfeld, A. S., Martin, E., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.737039 · Cited by 53
Large-Scale Recombinant Production of the SARS-CoV-2 Proteome for High-Throughput and Structural Biology Applications
Altincekic, N., Korn, S. M., Qureshi, N. S., Dujardin, M., Ninot‐Pedrosa, M., Abele, R., Saad, M. J. A., Alfano, C., Almeida, F. C. L., Alshamleh, I., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.653148 · Cited by 52
Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains
Lee, C. H.-J., Pinho, M. P., Buckley, P. R., Woodhouse, I. B., Ogg, G. S., Simmons, A., Napolitani, G., & Koohy, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.579480 · Cited by 55
The global succinylation of SARS-CoV-2–infected host cells reveals drug targets
Liu, Q., Wang, H., Zhang, H., Sui, L., Li, L., Xu, W., Du, S., Hao, P., Jiang, Y., Chen, J., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123065119 · Cited by 53
Unconventional viral gene expression mechanisms as therapeutic targets
Ho, J., Zhu, Z., & Marazzi, I. (2021) · Nature · doi:10.1038/s41586-021-03511-5 · Cited by 56
Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy
Bojková, D., Costa, R., Reus, P., Bechtel, M., Jaboreck, M.-C., Olmer, R., Martin, U., Ciesek, S., Michaelis, M., & Cinatl, J. J. (2021) · Metabolites · doi:10.3390/metabo11100699 · Cited by 55
Self-citation
Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants
Wagner, J. U. G., Bojkova, D., Shumliakivska, M., Luxán, G., Nicin, L., Aslan, G. S., Milting, H., Kandler, J. D., Dendorfer, A., Heumueller, A. W., et al. (2021) · Basic Research in Cardiology · doi:10.1007/s00395-021-00882-8 · Cited by 53
Self-citation
Identification of SARS-CoV-2–induced pathways reveals drug repurposing strategies
Han, N., Hwang, W., Tzelepis, K., Schmerer, P., Yankova, E., MacMahon, M., Lei, W., Katritsis, N. M., Liu, A., Felgenhauer, U., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh3032 · Cited by 55
SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viabilityPreprint
Crunfli, F., Carregari, V. C., Veras, F. P., Vendramini, P. H., Valença, A. G. F., Antunes, A. S. L. M., Brandão‐Teles, C., Zuccoli, G. S., Reis‐de‐Oliveira, G., Silva-Costa, L. C., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-104944/v1 · Cited by 53
Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans
Srivastava, R., Daulatabad, S. V., Srivastava, M., & Janga, S. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197090 · Cited by 52
Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution
Jungreis, I., Nelson, C. W., Ardern, Z., Finkel, Y., Krogan, N. J., Sato, K., Ziebuhr, J., Stern‐Ginossar, N., Pavesi, A., Firth, A. E., et al. (2021) · Virology · doi:10.1016/j.virol.2021.02.013 · Cited by 57
SRSF10: an atypical splicing regulator with critical roles in stress response, organ development, and viral replication
Shkreta, L., Delannoy, A., Salvetti, A., & Chabot, B. (2021) · RNA · doi:10.1261/rna.078879.121 · Cited by 51
SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19
Guarnieri, J. W., Haltom, J., Albrecht, Y. E. S., Lie, T., Olali, A. Z., Widjaja, G. A., Ranshing, S., Angelin, A., Murdock, D. G., & Wallace, D. C. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107170 · Cited by 55
Design and application of nanoparticles as vaccine adjuvants against human corona virus infection
Mao, L., Chen, Z., Wang, Y., & Chen, C. (2021) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2021.111454 · Cited by 56
The dark side of the spoon - glucose, ketones and COVID-19: a possible role for ketogenic diet?
Paoli, A., Gorini, S., & Caprio, M. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02600-9 · Cited by 51
The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models
Stegmann, K. M., Dickmanns, A., Gerber, S., Nikolova, V., Klemke, L., Manzini, V., Schlösser, D., Bierwirth, C., Freund, J., Sitte, M., et al. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198469 · Cited by 48
2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update
Huang, Z., Chavda, V. P., Vora, L. K., Gajjar, N. D., Apostolopoulos, V., Shah, N., & Chen, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.899633 · Cited by 51
A SARS-CoV-2 BioID-based virus-host membrane protein interactome and virus peptide compendium: new proteomics resources for COVID-19 researchPreprint
St‐Germain, J. R., Astori, A., Samavarchi‐Tehrani, P., Abdouni, H. S., Macwan, V., Kim, D., Knapp, J. J., Roth, F. P., Gingras, A., & Raught, B. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.28.269175 · Cited by 50
Host directed therapies: COVID-19 and beyond
Tripathi, D., Sodani, M., Gupta, P. K., & Kulkarni, S. (2021) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2021.100058 · Cited by 49
Quantitative proteomics reveals a broad‐spectrum antiviral property of ivermectin, benefiting for COVID‐19 treatment
Li, N., Zhao, L., & Zhan, X. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30055 · Cited by 48
Viral Infection Modulates Mitochondrial Function
Li, X., Wu, K., Zeng, S., Zhao, F., Fan, J., Li, Z., Yi, L., Ding, H., Zhao, M., Fan, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084260 · Cited by 49
Functionalized Terpolymer-Brush-Based Biointerface with Improved Antifouling Properties for Ultra-Sensitive Direct Detection of Virus in Crude Clinical Samples
Forinová, M., Pilipenco, A., Víšová, I., Lynn, N. S., Jr., Dostálek, J., Mašková, H., Hönig, V., Palus, M., Selinger, M., Kočová, P., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c16930 · Cited by 46
Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?
Chang, X., Ismail, N. I., Rahman, A., Xu, D., Chan, R. W. Y., Ong, S., & Ong, S. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0126 · Cited by 53
Coronavirus disease 2019 (COVID‐19) update: From metabolic reprogramming to immunometabolism
Rudiansyah, M., Jasim, S. A., pour, Z. G. M., Athar, S. S., Jeda, A. S., Doewes, R. I., Jalil, A. T., Bokov, D. O., Mustafa, Y. F., Noroozbeygi, M., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27929 · Cited by 47
In vitro activity of itraconazole against SARS‐CoV‐2
Damme, E. V., Meyer, S. D., Bojková, D., Ciesek, S., Cinatl, J. J., Jonghe, S. D., Jochmans, D., Leyssen, P., Buyck, C., Neyts, J. H., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26917 · Cited by 46
Self-citation
Metformin suppresses SARS-CoV-2 in cell culture
Parthasarathy, H., Tandel, D., Siddiqui, A. H., & Harshan, K. H. (2022) · Virus Research · doi:10.1016/j.virusres.2022.199010 · Cited by 46
Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology
Zheng, W., Yan, Q., Ni, Y., Zhan, S., Yang, L., Zhuang, H., Liu, X., & Jiang, Y. (2020) · BioData Mining · doi:10.1186/s13040-020-00227-6 · Cited by 46
Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses
Sperk, M., van Domselaar, R., Murillo, J. R., Mikaeloff, F., Vinhas, B. S., Saccon, E., Sönnerborg, A. B., Singh, K. D., Gupta, S., Végvári, Á., et al. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00380 · Cited by 47
CNBP Binds and Unfolds In Vitro G-Quadruplexes Formed in the SARS-CoV-2 Positive and Negative Genome Strands
Bezzi, G., Piga, E. J., Binolfi, A., & Armas, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052614 · Cited by 49
The Effect of Allicin on the Proteome of SARS-CoV-2 Infected Calu-3 Cells
Mösbauer, K., Fritsch, V. N., Adrian, L., Bernhardt, J., Gruhlke, M. C. H., Slusarenko, A. J., Niemeyer, D., & Antelmann, H. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.746795 · Cited by 57
Mechanisms contributing to adverse outcomes of COVID-19 in obesity
Sudhakar, M., Beaula, W. S., Meiyazhagan, G., & Parvathi, V. D. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04356-w · Cited by 50
SARS-CoV-2 Infection Triggers Phosphorylation: Potential Target for Anti-COVID-19 Therapeutics
Chatterjee, B., & Thakur, S. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.829474 · Cited by 45
2-deoxy-d-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trial
Bhatt, A. N., Shenoy, S., Munjal, S., Chinnadurai, V., Agarwal, A., Kumar, A., Shanavas, A., Kanwar, R. S., & Chandna, S. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07642-6 · Cited by 50
Recent Understandings Toward Coronavirus Disease 2019 (COVID-19): From Bench to Bedside
Yu, J., Chai, P., Ge, S., & Fan, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00476 · Cited by 45
Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets
Cheng, K., Martin‐Sancho, L., Pal, L. R., Pu, Y., Riva, L., Yin, X., Sinha, S., Nair, N. U., Chanda, S. K., & Ruppin, E. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110260 · Cited by 43
Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches
Çakır, M., Obernier, K., Forget, A., & Krogan, N. J. (2021) · mSystems · doi:10.1128/msystems.00388-21 · Cited by 45
Genome Scale-Differential Flux Analysis reveals deregulation of lung cell metabolism on SARS-CoV-2 infection
Nanda, P., & Ghosh, A. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008860 · Cited by 45
Proteomics of extracellular vesicles in plasma reveals the characteristics and residual traces of COVID-19 patients without underlying diseases after 3 months of recovery
Mao, K., Tan, Q., Ma, Y., Wang, S., Zhong, H., Liao, Y., Huang, Q., Xiao, W., Xia, H., Tan, X., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03816-3 · Cited by 43
COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the Heart
Pesce, M., Agostoni, P., Bøtker, H. E., Brundel, B. J. J. M., Davidson, S. M., Caterina, R. D., Ferdinandy, P., Girão, H., Gyöngyösi, M., Hulot, J., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab201 · Cited by 43
Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology
Villar, M., Urra, J. M., Rodríguez‐del‐Río, F. J., Artigas-Jerónimo, S., Jiménez-Collados, N., Ferreras‐Colino, E., Contreras, M., de Mera, I. G. F., Estrada‐Peña, A., Gortázar, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.730710 · Cited by 43
Machine Learning Assisted Prediction of Prognostic Biomarkers Associated With COVID-19, Using Clinical and Proteomics Data
Sardar, R., Sharma, A. B., & Gupta, D. K. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.636441 · Cited by 41

Authors: Bojkova, D., Klann, K., Koch, B., Widera, M., Krause, D., Ciesek, S., Cinatl, J., & Münch, C.
Affiliations: Goethe University Frankfurt (DE)
University Hospital Frankfurt (DE)
Corresponding author: Cinatl, Jindrich
Münch, Christian
ORCID: Klann, Kevin
Koch, Benjamin
Widera, Marek
Krause, David
Ciesek, Sandra
Cinatl, Jindrich
Münch, Christian
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2020-05-14
Volume: 583
Issue: 7816
Pages: 469-472
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/s41586-020-2332-7
PMC: PMC7616921
OpenAlex: W3026002191
Cited by: 1,010
References: 53
Citations by year: 2026: 25 · 2025: 58 · 2024: 86 · 2023: 118 · 2022: 198 · 2021: 347 · 2020: 177
FWCI: 27.46
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
Research Square (acceptedVersion, cc-by)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft) (submittedVersion)
Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
Funders: Frankfurter Stiftung für krebskranke Kinder
Hilfe für krebskranke Kinder Frankfurt
European Commission
Deutsche Forschungsgemeinschaft (ERC StG 803565, MU 4216/1-1, CRC 1177)
Aventis Foundation
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
Keywords: SARS-CoV-2, COVID-19 pandemic, viral replication, host-pathogen interaction, translation (biology), splicing, carbon metabolism, proteostasis, nucleic acid metabolism, small molecule inhibitors, antiviral drug targets, proteome, translatome
MeSH terms: Betacoronavirus, Proteostasis, COVID-19, SARS-CoV-2, COVID-19 Drug Treatment, Carbon, Drug Evaluation, Preclinical, Humans, Kinetics, Pneumonia, Viral, RNA Splicing, Time Factors, Protein Biosynthesis, Virus Replication, Coronavirus Infections, Caco-2 Cells, Proteome, Proteomics, Host-Pathogen Interactions, Pandemics, Molecular Targeted Therapy, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks